Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 4, 2009, Pages 398-404

  Petrášek, Jan ^a,g   Hubáček, Jaroslav A ^a   Stickel, Felix ^b   Šperl, Jan ^a   Berg, Thomas ^c   Ruf, Esther ^d   Wichmann, H Erich ^d,e   Pfeufer, Arne ^d,f   Meitinger, Thomas ^d,f   Trunečka, Pavel ^a   Špičák, Julius ^a   Jirsa, Milan ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY OF BERN   (Switzerland)

^c HUMBOLDT UNIVERSITY   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Alcoholic; Genetic; Interleukin 1 ; Liver cirrhosis; Polymorphism; Tumor necrosis factor

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

CASE-CONTROL STUDIES; ENDOTOXINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HEALTH; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; SIGNAL TRANSDUCTION;

EID: 63849311404     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.112     Document Type: Article

References (41)

1. Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001;35:531-7.
2. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997;41:845-50.
3. Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 2006; 41:209-24.
4. Reed T, Page WF, Viken RJ, Christian JC. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res 1996;20:1528-33.
5. Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 2006;26:1021-8.
6. Zintzaras E, Stefanidis I, Santos M, Vidal F. Do alcoholmetabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 2006;43:352-61.
7. Osterreicher CH, Stickel F, Brenner DA. Genomics of liver fibrosis and cirrhosis. Semin Liver Dis 2007;27: 28-43.
8. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, et al. Cytokines and alcohol. Alcohol Clin Exp Res 2006;30:720-30.
9. Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2007;23:283-91.
10. Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 2007;46:831-40.
11. Urbaschek R, McCuskey RS, Rudi V, Becker KP, Stickel F, Urbaschek B, et al. Endotoxin, endotoxin-neutralizingcapacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res 2001;25:261-8.
12. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcoholinduced liver injury. Hepatology 1994;20:453-60.
13. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following longterm exposure to ethanol. Gastroenterology 1995;108: 218-24.
14. Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, Goyert SM, et al. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001;166: 4737-42.
15. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001; 34:101-8.
16. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997;94: 8093-8.
17. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-52.
18. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, et al. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 1996;157:291-6.
19. Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996;93: 11008-13.
20. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999;99: 3218-20.
21. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
22. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001;14:316-23.
23. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
24. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
25. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998;47: 195-8.
26. Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for lcoholic liver disease. Hepatology 2001;33:1148-53.
27. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S, Uchikoshi T. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 2000;95:1305-11.
28. Chen WX, Xu GY, Yu CH, Wang P, Yu M, Xu P, et al. Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease. Hepatobil Pancreat Dis Int 2005;4:41-5.
29. Pastor IJ, Laso FJ, Romero A, Gonzalez-Sarmiento R.-238 G>A polymorphism of tumor necrosis factor alphagene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men. Alcohol Clin Exp Res 2005; 29:1928-31.
30. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997;26:143-6.
31. Tunstall-Pedoe H, Kuulasmaa K, Tolonen H, Davidson M, Mendis S. In: Tunstall-Pedoe H, editor. MONICA monograph and multimedia sourcebook. Geneva: World Health Organization, 2003.
32. Wichmann HE, Gieger C, Illig T. KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005;67 (Suppl 1):S26-30.
33. Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res 2005; 15:1592-3.
34. Gaunt TR, Rodriguez S, Zapata C, Day IN. MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinformatics 2006;7:227.
35. Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F,Perez LF, Torre JA, et al. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acutephase proteins in heavy drinkers. Alcohol Clin Exp Res 2005;29:1206-13.
36. Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Miyazoe S, et al. Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. J Hepatol 2007;46:381-6.
37. Dominici R, Malferrari G, Mariani C, Grimaldi L, Biunno I. The Interleukin 1-beta exonic (q3953) polymorphism does not alter in vitro protein secretion. Exp Mol Pathol 2002;73:139-41.
38. Daly AK, Day CP. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001;52:489-99.
39. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005;366:1315-23.
40. Nguyen-Khac E, Houchi H, Daoust M, Dupas JL, Naassila M. The -308 TNFalpha gene polymorphism in severe acute alcoholic hepatitis: identification of a new susceptibility marker. Alcohol Clin Exp Res 2008;32:822-8.
41. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.